Structure–activity relationship analysis of a series of nonsteroidal analogues as androgen receptor antagonists

Abstract

Computer-aided drug design technology was used to screen drugs in large-scale and to accelerate the progress of drug design of nonsteroidal compounds deriving from the hybridization of FDA-approved Enzalutamide and Abiraterone.